Oxycodone represents 37.5% within the product segment, surgical pain accounts for 45.7% of the indication category and oral administration holds 62.3% of route of administration demand in 2025. The opioid analgesics market was valued at USD 48.5 billion in 2025 and is forecast to post a 4.8% CAGR between 2025 and 2035.